equipments data

Insights into Genetic Diversity, Runs of Homozygosity and Heterozygosity-Rich Regions in Maremmana Semi-Feral Cattle Using Pedigree and Genomic Data

Posted by Norman Walker on in Antibodies, Assay Kits, Assessment of Autozygosity Derived From Runs of Homozygosity in Jinhua Pigs Disclosed by Sequencing Data., Autozygosity and Genetic Differentiation of Landrace and Large White Pigs as Revealed by the Genetic Analyses of Crossbreds., Biology Cells, Clia Kits, Culture Cells, Default, Devices, DNA, Effects of autozygosity and schizophrenia polygenic risk on cognitive and brain developmental trajectories., Elisa Kits, Enzymes, Equipments, Exosomes, Gels, Isotypes, NATtrol, Panel
Insights into Genetic Diversity, Runs of Homozygosity and Heterozygosity-Rich Regions in Maremmana Semi-Feral Cattle Using Pedigree and Genomic Data

Semi-feral native livestock populations, like Maremmana cattle, are the thing of renewed curiosity for the conservation of organic variety and the preservation and exploitation of distinctive and doubtlessly related genetic materials. The intention of this examine was to estimate genetic variety parameters in semi-feral Maremmana cattle utilizing each pedigree- and genomic-based approaches (FIS and FROH), and to detect areas of homozygosity (ROH) and heterozygosity (ROHet) in the genome.

The common heterozygosity estimates have been in the vary reported for different cattle breeds (HE=0.261, HO=0.274). Pedigree-based common inbreeding (F) was estimated at 4.9%. The correlation was low between F and genomic-based approaches (r=0.03 with FIS, r=0.21 with FROH), whereas it was increased between FIS and FROH (r=0.78).

The low correlation between F and FROH coefficients would be the end result of the restricted pedigree depth out there for the animals concerned in this examine. The ROH islands recognized in Maremmana cattle included candidate genes related to local weather adaptation, carcass traits or the regulation of physique weight, fats and vitality metabolism.

The ROHet islands contained candidate genes related to nematode resistance and replica traits in livestock. The outcomes of this examine affirm that genome-based measures like FROH could also be helpful estimators of particular person autozygosity, and could present insights on pedigree-based inbreeding estimates in instances when animals’ pedigree knowledge are unavailable, thus offering a extra detailed image of the genetic variety.

Inbreeding coefficients and runs of homozygosity islands in Brazilian water buffalo

Characterization of autozygosity is related to observe genetic variety and handle inbreeding ranges in breeding packages. Identification of autozygosity hotspots can unravel genomic areas focused by choice for economically necessary traits and may help establish candidate genes for choice. In this examine, we estimated the inbreeding ranges of a Brazilian inhabitants of Murrah buffalo present process choice for milk manufacturing traits, significantly milk yield.

We additionally studied the distribution of runs of homozygosity (ROH) islands and recognized putative genes and quantitative trait loci (QTL) beneath choice. We genotyped 422 Murrah buffalo for 51,611 SNP; 350 of these had ROH longer than 10 Mb, indicating the incidence of inbreeding in the final 5 generations.

The imply size of the ROH per animal was 4.28 ± 1.85 Mb. Inbreeding coefficients have been calculated from the genomic relationship matrix, the pedigree, and the ROH, with estimates various between 0.242 and 0.035. Inbreeding estimates from the pedigree had a low correlation with the genomic estimates, and estimates from the genomic relationship matrix have been a lot increased than these from the pedigree or the ROH.

Signatures of choice have been recognized in 6 genomic areas, positioned on chromosomes 1, 2, 3, 5, 16, and 18, encompassing a complete of 190 genes and 174 QTL. Many of the genes (e.g., APRT and ACSF3) and QTL recognized are associated to exploit manufacturing traits, comparable to milk yield, milk fats yield and proportion, and milk protein yield and proportion. Other genes are related to replica and immune response traits in addition to morphological points of the buffalo species.

Inbreeding ranges in this inhabitants are nonetheless low however are growing resulting from choice and needs to be managed to keep away from future losses resulting from inbreeding melancholy. The proximity of genes linked to exploit manufacturing traits with genes related to replica and immune system traits suggests the necessity to embody these latter genes in the breeding program to keep away from negatively affecting them resulting from choice for manufacturing traits.

Insights into Genetic Diversity, Runs of Homozygosity and Heterozygosity-Rich Regions in Maremmana Semi-Feral Cattle Using Pedigree and Genomic Data

Genome-wide evaluation of homozygosity areas in european simmental bulls

The examine of Runs of Homozygosity (ROH) is a helpful strategy for the characterization of the genome of livestock populations. Due to their excessive relationship with autozygosity, ROH enable to make inference about inhabitants genetic historical past, to estimate the extent of inbreeding, to evaluate inside breed heterogeneity and to detect the footprints of choice on livestock genomes.

Aim of this examine was to analyze the distribution of runs of homozygosity in bulls belonging to 5 European Simmental populations and to evaluate the connection between three manufacturing traits (milk yield, fats and protein contents) and autozygosity. ROH rely, distribution and ROH-based coefficient of inbreeding (FROH ) have been calculated for 3,845 Simmental bulls of 5 totally different European nations: Austria (AT), Switzerland (CH), Czech Republic (CZ), Germany (DE) and Italy (IT).

Carcinoembryonic Antigen CEA
MBS5763549-5x25mg 5x25mg
EUR 8355

Carcinoembryonic Antigen (CEA)
MBS556148-05mL 0.5mL
EUR 455

Carcinoembryonic Antigen (CEA)
MBS556148-5x05mL 5x0.5mL
EUR 1895

Carcinoembryonic Antigen (CEA)
MBS590046-192Wells 192Wells
EUR 915

Carcinoembryonic Antigen (CEA)
MBS590046-3x192Wells 3x192Wells
EUR 2235

Carcinoembryonic Antigen (CEA)
MBS590046-96Wells 96Wells
EUR 550

Carcinoembryonic Antigen (CEA)
MO47049 0.5 ml
EUR 278.1

Carcinoembryonic antigen (CEA)
RP-4005-01 0.5 ml
EUR 136.15

Carcinoembryonic antigen (CEA)
RP-4005-02 1.0 ml
EUR 198.8

Carcinoembryonic Antigen CEA
TP1286-10mg 10mg Ask for price
Description: Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen CEA
TP1286-1g 1g Ask for price
Description: Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen CEA
TP1286-1mg 1mg Ask for price
Description: Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen CEA
TP1286-50mg 50mg Ask for price
Description: Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen CEA
TP1286-5mg 5mg Ask for price
Description: Carcinoembryonic Antigen CEA

Carcinoembryonic Antigen, Human
MBS382004-01mg 0.1mg
EUR 230

Carcinoembryonic Antigen, Human
MBS382004-1mg 1mg
EUR 630

Carcinoembryonic Antigen, Human
MBS382004-5x1mg 5x1mg
EUR 2745

Carcinoembryonic Antigen Protein
abx262093-10mg 10 mg
EUR 6575

Carcinoembryonic Antigen Protein
20-abx262093
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 ug
  • 1 mg

Carcinoembryonic Antigen Protein
abx262093-5mg 5 mg
EUR 325

Human carcinoembryonic antigen (CEA) antigen
CEA15-N-100 100 ug
EUR 270

Carcinoembryonic Antigen Antibody
38106 100ul
EUR 319

Carcinoembryonic Antigen Antibody
38106-100ul 100ul
EUR 302.4

Carcinoembryonic Antigen Antibody
38106-50ul 50ul
EUR 224.4

Carcinoembryonic Antigen Antibody
E038106 100μg/100μl
EUR 255
Description: Available in various conjugation types.

Carcinoembryonic Antigen Antibody
MBS9400129-01mL 0.1mL
EUR 305

Carcinoembryonic Antigen Antibody
MBS9400129-5x01mL 5x0.1mL
EUR 1230

Carcinoembryonic Antigen (CEA) 80%
GWB-DE92F6 1 mg Ask for price

Carcinoembryonic Antigen (CEA) 95%
GWB-621CF0 0.5 mg Ask for price

Carcinoembryonic Antigen (CEA) 98%
GWB-7EAB80 0.5 mg Ask for price

Carcinoembryonic Antigen (CEA) 95%
GWB-19A52D 0.1 mg Ask for price

Carcinoembryonic Antigen (CEA) 98%
GWB-1A3E2F 1 mg Ask for price

Carcinoembryonic Antigen (CEA) >95%
MBS569560-1mg 1mg
EUR 1010

Carcinoembryonic Antigen (CEA) >95%
MBS569560-5x1mg 5x1mg
EUR 4345

Carcinoembryonic Antigen (CEA) >95%
MBS569853-1mg 1mg
EUR 1010

Carcinoembryonic Antigen (CEA) >95%
MBS569853-5x1mg 5x1mg
EUR 4345

CEA (Carcinoembryonic antigen) (AP)
MBS6404226-01mL 0.1mL
EUR 890

CEA (Carcinoembryonic antigen) (AP)
MBS6404226-5x01mL 5x0.1mL
EUR 3855

CEA (Carcinoembryonic antigen) (PE)
MBS6404236-01mL 0.1mL
EUR 890

CEA (Carcinoembryonic antigen) (PE)
MBS6404236-5x01mL 5x0.1mL
EUR 3855

Carcinoembryonic Antigen (CEA) (PE)
MBS6129160-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (PE)
MBS6129160-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (PE)
MBS6129161-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (PE)
MBS6129161-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (PE)
MBS6129162-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (PE)
MBS6129162-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (PE)
MBS6129163-01mL 0.1(mL
EUR 1070

Carcinoembryonic Antigen (CEA) (PE)
MBS6129163-5x01mL 5x0.1mL
EUR 4665

Carcinoembryonic Antigen (CEA) (PE)
MBS6129164-01mL 0.1(mL
EUR 1045

Carcinoembryonic Antigen (CEA) (PE)
MBS6129164-5x01mL 5x0.1mL
EUR 4545

Carcinoembryonic Antigen (CEA) (PE)
MBS6129165-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (PE)
MBS6129165-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (PE)
MBS6129166-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (PE)
MBS6129166-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (AP)
MBS6126066-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (AP)
MBS6126066-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (AP)
MBS6126067-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (AP)
MBS6126067-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (AP)
MBS6126068-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (AP)
MBS6126068-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (AP)
MBS6126069-01mL 0.1(mL
EUR 1070

Carcinoembryonic Antigen (CEA) (AP)
MBS6126069-5x01mL 5x0.1mL
EUR 4665

Carcinoembryonic Antigen (CEA) (AP)
MBS6126070-01mL 0.1(mL
EUR 1045

Carcinoembryonic Antigen (CEA) (AP)
MBS6126070-5x01mL 5x0.1mL
EUR 4545

Carcinoembryonic Antigen (CEA) (AP)
MBS6126071-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (AP)
MBS6126071-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (AP)
MBS6126072-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (AP)
MBS6126072-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) >95%
ND-R0784 1 Each Ask for price

Carcinoembryonic Antigen (101-115) (CEA)
MBS658793-1mg 1mg
EUR 610

Carcinoembryonic Antigen (101-115) (CEA)
MBS658793-5x1mg 5x1mg
EUR 2600

CEA (Carcinoembryonic antigen) (APC)
MBS6404227-01mL 0.1mL
EUR 890

CEA (Carcinoembryonic antigen) (APC)
MBS6404227-5x01mL 5x0.1mL
EUR 3855

CEA (Carcinoembryonic antigen) (HRP)
MBS6404230-01mL 0.1mL
EUR 890

CEA (Carcinoembryonic antigen) (HRP)
MBS6404230-5x01mL 5x0.1mL
EUR 3855

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128539-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128539-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128540-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128540-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128541-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128541-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128542-01mL 0.1(mL
EUR 1070

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128542-5x01mL 5x0.1mL
EUR 4665

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128543-01mL 0.1(mL
EUR 1045

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128543-5x01mL 5x0.1mL
EUR 4545

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128544-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128544-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128545-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (HRP)
MBS6128545-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (APC)
MBS6126684-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (APC)
MBS6126684-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (APC)
MBS6126685-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (APC)
MBS6126685-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (APC)
MBS6126686-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (APC)
MBS6126686-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (APC)
MBS6126687-01mL 0.1(mL
EUR 1070

Carcinoembryonic Antigen (CEA) (APC)
MBS6126687-5x01mL 5x0.1mL
EUR 4665

Carcinoembryonic Antigen (CEA) (APC)
MBS6126688-01mL 0.1(mL
EUR 1045

Carcinoembryonic Antigen (CEA) (APC)
MBS6126688-5x01mL 5x0.1mL
EUR 4545

Carcinoembryonic Antigen (CEA) (APC)
MBS6126689-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (APC)
MBS6126689-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (APC)
MBS6126690-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (APC)
MBS6126690-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e) (AP)
MBS6122117-01mL 0.1(mL
EUR 935

Carcinoembryonic Antigen (Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e) (AP)
MBS6122117-5x01mL 5x0.1mL
EUR 4050

Carcinoembryonic Antigen (Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e) (PE)
MBS6122122-01mL 0.1(mL
EUR 935

Carcinoembryonic Antigen (Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66e) (PE)
MBS6122122-5x01mL 5x0.1mL
EUR 4050

Carcinoembryonic Antigen (CEA)/CD66
MBS439843-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

Carcinoembryonic Antigen (CEA)/CD66
MBS439843-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439843-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439843-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439843-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439845-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

Carcinoembryonic Antigen (CEA)/CD66
MBS439845-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439845-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439845-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439845-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439847-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

Carcinoembryonic Antigen (CEA)/CD66
MBS439847-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439847-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439847-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439847-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439848-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

Carcinoembryonic Antigen (CEA)/CD66
MBS439848-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439848-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS439848-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS439848-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Carcinoembryonic Antigen (CEA)/CD66
MBS4380785-05mL 0.5mL
EUR 405

Carcinoembryonic Antigen (CEA)/CD66
MBS4380785-5x05mL 5x0.5mL
EUR 1725

CEA (Carcinoembryonic antigen) (FITC)
MBS6404229-01mL 0.1mL
EUR 890

CEA (Carcinoembryonic antigen) (FITC)
MBS6404229-5x01mL 5x0.1mL
EUR 3855

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127923-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127923-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127924-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127924-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127925-01mL 0.1(mL
EUR 1105

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127925-5x01mL 5x0.1mL
EUR 4830

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127926-01mL 0.1(mL
EUR 1070

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127926-5x01mL 5x0.1mL
EUR 4665

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127927-01mL 0.1(mL
EUR 1045

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127927-5x01mL 5x0.1mL
EUR 4545

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127928-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127928-5x01mL 5x0.1mL
EUR 5345

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127929-01mL 0.1(mL
EUR 1220

Carcinoembryonic Antigen (CEA) (FITC)
MBS6127929-5x01mL 5x0.1mL
EUR 5345

Recombinant Carcinoembryonic Antigen
VAng-Cr3880-1mg 1 mg
EUR 2188.8
Description: Recombinant Carcinoembryonic Antigen, Host/Source: Mammalian Cell Expression System. The purity is> 95% by SDS-PAGE.

Carcinoembryonic Antigen (CEA), Human
MBS170352-01mg 0.1mg
EUR 440

Average values of ROH quantity per animal, and whole genome size lined by ROH have been 77.8 ± 20.7 and 205 ± 74.4 Mb, respectively. Bulls from AT, DE and IT exhibited comparable ROH traits. Swiss animals confirmed the best (12.6%), whereas CZ the bottom (4.6%) FROH coefficient.

The relationship between ROH incidence and milk manufacturing traits was investigated by means of a genome-wide ROH-traits affiliation evaluation (GWRA). A complete of 34 areas beforehand related to milk traits (yield and/or composition) have been recognized by GWRA.

Results of the current analysis spotlight a combined genetic background in the 5 European Simmental populations, with the doable presence of three subgroups. Moreover, a robust relationship between autozygosity and manufacturing traits has been detected.